Repository logo
 

Developmental programming: State-of-the-science and future directions-Summary from a Pennington Biomedical symposium.

Accepted version
Peer-reviewed

Loading...
Thumbnail Image

Type

Article

Change log

Authors

Sutton, EF 
Gilmore, LA 
Dunger, DB 
Heijmans, BT 
Hivert, M-F 

Abstract

OBJECTIVE: On December 8-9, 2014, the Pennington Biomedical Research Center convened a scientific symposium to review the state-of-the-science and future directions for the study of developmental programming of obesity and chronic disease. The objectives of the symposium were to discuss: (i) past and current scientific advances in animal models, population-based cohort studies, and human clinical trials, (ii) the state-of-the-science of epigenetic-based research, and (iii) considerations for future studies. RESULTS: This symposium provided a comprehensive assessment of the state of the scientific field and identified research gaps and opportunities for future research in order to understand the mechanisms contributing to the developmental programming of health and disease. CONCLUSIONS: Identifying the mechanisms which cause or contribute to developmental programming of future generations will be invaluable to the scientific and medical community. The ability to intervene during critical periods of prenatal and early postnatal life to promote lifelong health is the ultimate goal. Considerations for future research including the use of animal models, the study design in human cohorts with considerations about the timing of the intrauterine exposure, and the resulting tissue-specific epigenetic signature were extensively discussed and are presented in this meeting summary.

Description

Keywords

Animals, Biomedical Research, Body Patterning, Chronic Disease, Epigenomics, Humans, Models, Animal, Obesity, Program Development, Research Design

Journal Title

Obesity (Silver Spring)

Conference Name

Journal ISSN

1930-7381
1930-739X

Volume Title

24

Publisher

Wiley
Sponsorship
Biotechnology and Biological Sciences Research Council (BB/F02293X/1)
Medical Research Council (MC_UU_12012/4)
Medical Research Council (G1001333)
British Heart Foundation (None)
Medical Research Council (MC_PC_12012)
The symposium was funded by NORC Center Grant P30DK072476 from the NIDDK. LAG is supported by T32DK064584 from the NIDDK. Work in MS Laboratory was supported by MOP‐42411 from the Canadian Institute of Health Research. Work in JAM Laboratory was supported by the Center for Nutrition Research at the University of Navarra in Pamplona, Spain. RAW is supported by a grant from the U.S. Department of Agriculture (USDA) [CRIS 3092‐5‐001‐059]. Work in BTH Laboratory was supported by the National Institutes of Health (R01AG042190) and the European Union's Seventh Framework Program IDEAL (FP7/2007‐2011; grant agreement No. 259679). Work in CL Laboratory was funded by The Swedish Research Council and The Novo Nordisk Foundation. SEO is a member of the University of Cambridge MRC Metabolic Diseases Unit. MFH is the recipient of an American Diabetes Association (ADA) Pathways To Stop Diabetes Award. Work in ER and LMR Laboratories was partially funded by a NORC grant titled “Nutritional Programming: Environmental and Molecular Interactions” to ER (P30DK072476).